WESTLAKE VILLAGE, Calif., April 02, 2012 — Envy Medical Inc. unveiled a new skin health advancement at the American Academy of Dermatology (AAD) Annual Meeting in San Diego in March, 2012. The Lumixyl Topical Brightening System, a medical professional skin care line first launched in 2010, now features the new Lumixyl GlycoPeel 10 Brightening Exfoliator, formulated with the patented Lumixyl peptide for the broadest range of skin types. Lumixyl GlycoPeel 10 Brightening Exfoliator promotes even skin tone, while also stimulating healthy skin function and cellular turnover.
This latest Lumixyl product is the first and only brightening exfoliator with Decapeptide-12. First introduced in the popular Lumixyl Topical Brightening Creme, Decapeptide-12 is the Stanford University discovery that is clinically shown to reduce the appearance of hyperpigmentation in skin without causing irritation or redness associated with other brightening agents. The new Lumixyl GlycoPeel 10 Brightening Exfoliator is a uniquely gentle glycolic gel-lotion designed especially for normal to sensitive skin types. By combining the acton of the peptide with the glycolic celluar turnover stimulation, it produces even faster brightening results within the Lumixyl Topical Brightening System. GlycoPeel 10 also contains Bisabolol, an ingredient that soothes and calms irritation, ensuring that the most sensitive complexions will enjoy maximum tolerability and minimal irritation, even when used twice daily. It is an advancement in getting significant visible results that once required prescription strength ingredients, without the worry of prescription ingredient skin irritation or side effects.
“The Lumixyl Topical Brightening System products are the first really exciting alternatives to hydroquinone solutions available through dermatologists across the country,” says Curtis A. Cluff, Chief Executive Officer of Envy Medical, Inc. “The GlycoPeel 10 Brightening Exfoliator is another revolution for the system. It is being embraced by even the most sensitive skin types, allowing for twice-daily use. Multiple applications of the Decapeptide-12 accelerates the achievement of diminished hyperpigmentation along with younger looking and healthier acting skin.”
The new Lumixyl Revitaleyes Brightening Eye Cream, first introduced last November, is now being used by patients of a growing number of physicians worldwide. Revitaleyes is the first and only eye cream leveraging Decapeptide-12 in addressing all of the major causes of dark circles under the eyes.
The Lumixyl line of professional skin care products are sold through dermatology, cosmetic surgery and medical spa physicians throughout the United States. Suggested retail price for Lumixyl GlycoPeel 10 is $145 per 2 oz bottle, and it is also available as part of the four step Lumixyl Topical Brightening System for best results. Together, the four Lumixyl products (Active-Prep Cleanser – $35; Topical Brightening Creme – $120; GlycoPeel 10 Brightening Exfoliator – $145; and MoistureLock Sunscreen SPF30 – $58) are specially priced at $288.00 (a $70 savings versus individual purchase). For more information go to www.envymedical.com, or contact firstname.lastname@example.org.
ABOUT ENVY MEDICAL — Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company’s lead products include SilkPeel®, a breakthrough device combining exfoliation with Dermalinfusion™ for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available in a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage. More information can be found at www.envymedical.com.
SOURCE Envy Medical Inc.